ESTIMATION OF ENTECAVIR IN PURE AND PHARMACEUTICAL FORMULATION BY USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.05, No. 04)Publication Date: 2018-04-09
Authors : Rameshpetchi Rajendran Devikasubramaniyan Ramya Sri Sura M. Praveen Kumar L.Soundharya M. Arun Kumar M. Sumalatha;
Page : 2073-2079
Keywords : Entecavir; RP-HPLC; validation;
Abstract
A rapid and precise Reverse Phase High Performance Liquid Chromatographic method has been developed for the validated of Entecavir, in its pure form as well as in tablet dosage form. Chromatography was carried out on a Phenomenex Gemini C18 (4.6 x 250mm, 5µm) column using a mixture of Acetonitrile and Water (15:85% v/v) as the mobile phase at a flow rate of 0.9ml/min, the detection was carried out at 215nm. The retention time of the Entecavir was 3.1 ±0.02min. The method produce linear responses in the concentration range of 30-150µg/ml of Entecavir. The method precision for the determination of assay was below 2.0%RSD. The method is useful in the quality control of bulk and pharmaceutical formulations. Keywords: Entecavir, RP-HPLC, validation.
Other Latest Articles
- METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DOSULEPIN IN PURE AND DOSAGE FORM BY USING HPLC
- FORMULATION AND EVALUATION OF CEFADROXIL MUCOADHESIVE TABLETS
- VALIDATED HPLC METHOD FOR ESTIMATION OF BALOFLOXACIN IN BULK AND DOSAGE FORM
- RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ALPRAZOLAM AND IMIPRAMINE AS PER ICH GUIDELINES
- SIGNIFICANCE AND VALUE OF BUSINESS INFORMATION AND MEASURES OF PROTECTION IN THE INDUSTRIAL ESPIONAGE
Last modified: 2018-04-09 23:23:38